Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences: Psychiatry

Adding SISCOM to routine evaluation of brain SPECT studies for determining rCBF alterations after medication in schizophrenia

Eser Ergün, Bilge Salanci, Aygün Ertugrul, Basaran Demir and Belkis Erbas
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 260P;
Eser Ergün
1Department of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bilge Salanci
1Department of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aygün Ertugrul
2Department of Psychiatry, Hacettepe University, School of Medicine, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Basaran Demir
2Department of Psychiatry, Hacettepe University, School of Medicine, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Belkis Erbas
1Department of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 48 no. supplement 2 260P

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online October 31, 2014.

Copyright & Usage 
Society of Nuclear Medicine, Inc.

Author Information

  1. Eser Ergün1,
  2. Bilge Salanci1,
  3. Aygün Ertugrul2,
  4. Basaran Demir2 and
  5. Belkis Erbas1
  1. 1Department of Nuclear Medicine;
  2. 2Department of Psychiatry, Hacettepe University, School of Medicine, Ankara, Turkey

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: December 2014 to April 2025

AbstractFullPdf
Dec 2014100
Jan 2015200
Mar 2015100
Sep 2015400
Nov 2015100
Feb 2016200
Mar 2016300
Apr 2016100
May 2016600
Jun 2016200
Nov 2016600
Feb 2017300
Apr 2017300
May 2017100
Jul 2017100
Aug 2017200
Sep 2017300
Oct 2017100
Dec 2017100
Mar 2018300
Apr 2018200
Jun 2018100
Apr 2019100
May 2019100
Nov 2019100
Jan 2020100
Feb 2020300
Mar 20201400
Apr 2020800
Jul 2020100
Aug 20204900
Sep 20204700
Oct 2020300
Nov 2020900
Dec 2020700
Jan 2021100
Feb 2021900
Mar 2021800
Apr 2021900
May 2021700
Jun 20212000
Jul 20211100
Aug 20212000
Sep 2021700
Oct 20212300
Nov 20212400
Dec 20211800
Jan 20223400
Feb 20221000
Mar 20222600
Apr 20221300
May 20221100
Jun 2022200
Jul 2022100
Aug 2022100
Sep 2022100
Oct 2022100
Dec 2022200
Feb 2023100
Mar 2023100
May 2023400
Jun 2023200
Jul 2023200
Aug 2023300
Sep 2023100
Oct 2023500
Nov 2023100
Dec 2023700
Jan 2024300
Mar 2024600
Apr 2024300
May 2024200
Jun 2024600
Jul 2024100
Aug 2024900
Sep 2024100
Oct 2024800
Nov 2024300
Dec 2024400
Jan 2025200
Mar 2025300
Apr 2025300
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Adding SISCOM to routine evaluation of brain SPECT studies for determining rCBF alterations after medication in schizophrenia
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Adding SISCOM to routine evaluation of brain SPECT studies for determining rCBF alterations after medication in schizophrenia
Eser Ergün, Bilge Salanci, Aygün Ertugrul, Basaran Demir, Belkis Erbas
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 260P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Adding SISCOM to routine evaluation of brain SPECT studies for determining rCBF alterations after medication in schizophrenia
Eser Ergün, Bilge Salanci, Aygün Ertugrul, Basaran Demir, Belkis Erbas
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 260P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences: Psychiatry

  • Brain glucose metabolism changes following thyroid function normalization in hyperthyroidism
  • Thalamic glucose metabolism matched with ultra high resolution anatomy and tractography obtained by PET-MRI fusion imaging
  • Shape analysis method can be used for limited non-invasive estimation of striatal and cerebellar [11C]-PMP k3 hydrolysis rates
Show more Neurosciences: Psychiatry

Psychiatry Posters

  • Towards characterizing the regional cerebral perfusion in evaluating the severity of major depression disorder by SPECT/CT
  • A pilot PET/MR study of hippocampal, diffusivity and brain metabolism changes following electroconvulsive therapy
  • Naltrexone occupancy at kappa opioid receptors investigated in alcoholics by PET occupancy at kappa opioid receptors investigated in alcoholics by PET
Show more Psychiatry Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire